Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Aishwarya Ravindran, MBBS, Andrew L. Feldman, MD, Rhett P. Ketterling, MD, Surendra Dasari, PhD, Karen Rech, MD, Ellen D. McPhail, MD, Paul J Kurtin, MD, Min Shi, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134547

Published: 2020

Journal Articles

High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?

Priyanka Pophali, MD, Lisa M Marinelli, Rhett P. Ketterling, Reid Gregory Meyer, Ellen D. McPhail, MD, Paul J Kurtin, MD, Thomas M. Habermann, MD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 1693.

https://doi.org/10.1182/blood-2018-99-115484

Published: 2018

Journal Articles

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Thomas M. Habermann, MD, Ruth A Lentz, R.N., John J Schmitz, MD, Alexander G von Bormann, BA, Jason Young, MD, Christopher H Hunt, MD, Grzegorz S. Nowakowski, MD, Kristen McCullough, PharmD, Pedro Horna, MD, Adam J Wood, MD, William R. Macon, MD, Paul J Kurtin, MD, Scott L Stafford, MD, Usha Sree Chamarthy, MD, Faraz Khan, MD, Stephen M. Ansell, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 2247.

https://doi.org/10.1182/blood-2018-99-112887

Published: 2018

Journal Articles

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry

Taxiarchis V. Kourelis, Surendra Dasari, Jason D. Theis, Marina Ramirez-Alvarado, Paul J. Kurtin, Morie A. Gertz, Steven R. Zeldenrust, Roman M. Zenka, Ahmet Dogan, Angela Dispenzieri

Blood (2017) 129 (3): 299–306.

https://doi.org/10.1182/blood-2016-10-743997

Published: 2017

Includes: Supplemental data

Journal Articles

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Ellen D. McPhail, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, William R. Macon, MD, Andrew L Feldman, MD, Paul J Kurtin, MD, Thomas E. Witzig, MD, Rakhee Vaidya, MD, Thomas M. Habermann, MD

Blood (2016) 128 (22): 1750.

https://doi.org/10.1182/blood.V128.22.1750.1750

Published: 2016

Journal Articles

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Thomas M. Habermann, MD, William R. Macon, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, Paul J Kurtin, MD, Andrew L Feldman, MD, Rakhee Vaidya, MD, James R Cerhan, MD PhD, Stephen Ansell, MD PhD, Luis Porrata, MD, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Ellen D. McPhail, MD

Blood (2016) 128 (22): 155.

https://doi.org/10.1182/blood.V128.22.155.155

Published: 2016

Journal Articles

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Blood (2016) 128 (9): 1234–1245.

https://doi.org/10.1182/blood-2016-03-707141

Published: 2016

Includes: Supplemental data

Journal Articles

Immunoglobulin Variable Region Family Usage and Outcomes of Patients with Systemic Light Chain Amyloidosis

Taxiarchis Kourelis, MD, Surendra Dasari, PhD, Paul J Kurtin, MD, Marina Ramirez-Alvarado, PhD, Steven R Zeldenrust, MD PhD, Jason D Theis, BS, Morie A Gertz, MD, Ahmet Dogan, MDPhD, Angela Dispenzieri, MD

Blood (2014) 124 (21): 3402.

https://doi.org/10.1182/blood.V124.21.3402.3402

Published: 2014

Journal Articles

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Oana M. Mereuta, Jason D. Theis, Julie A. Vrana, Mark E. Law, Karen L. Grogg, Surendra Dasari, Vishal S. Chandan, Tsung-Teh Wu, Victor H. Jimenez-Zepeda, Rafael Fonseca, Angela Dispenzieri, Paul J. Kurtin, Ahmet Dogan

Blood (2014) 123 (10): 1479–1482.

https://doi.org/10.1182/blood-2013-07-517938

Published: 2014

Includes: Supplemental data

Journal Articles

Mass Spectrometry-Based Proteomics Reveals Distinct Immunoglobulin Light Chain Variable Region Usage In Systemic Versus Localized AL Amyloidosis

Oana M Mereuta, M.D., Ph.D., Surendra Dasari, Ph.D, Jason D Theis, BS, Julie A Vrana, Ph.D., Karen L Grogg, M.D., Morie A Gertz, M.D., Steven R. Zeldenrust, M.D., Ph.D., Angela Dispenzieri, MD, Marina Ramirez-Alvarado, Ph.D., Diane F. Jelinek, PhD, Paul J Kurtin, MD, Ahmet Dogan, MD, PhD

Blood (2013) 122 (21): 3142.

https://doi.org/10.1182/blood.V122.21.3142.3142

Published: 2013

Journal Articles

Proteome Of Amyloidosis: Mayo Clinic Experience In 4139 Cases

Jason D Theis, BS, Surendra Dasari, Ph.D, Julie A Vrana, Ph.D., Oana M Mereuta, M.D., Ph.D., Karen L Grogg, M.D., Morie A Gertz, M.D., Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Paul J Kurtin, MD, Ahmet Dogan, MD, PhD

Blood (2013) 122 (21): 1900.

https://doi.org/10.1182/blood.V122.21.1900.1900

Published: 2013

Journal Articles

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

Blood (2013) 122 (21): 362.

https://doi.org/10.1182/blood.V122.21.362.362

Published: 2013

Journal Articles

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Blood (2011) 118 (18): 4882–4889.

https://doi.org/10.1182/blood-2011-02-334904

Published: 2011

Journal Articles

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Ivana N. M. Micallef, Matthew J. Maurer, Gregory A. Wiseman, Daniel A. Nikcevich, Paul J. Kurtin, Michael W. Cannon, Domingo G. Perez, Gamini S. Soori, Brian K. Link, Thomas M. Habermann, Thomas E. Witzig

Blood (2011) 118 (15): 4053–4061.

https://doi.org/10.1182/blood-2011-02-336990

Published: 2011

Journal Articles

Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients

Linda N. Dao, Curtis A. Hanson, Angela Dispenzieri, William G. Morice, Paul J. Kurtin, James D. Hoyer

Blood (2011) 117 (24): 6438–6444.

https://doi.org/10.1182/blood-2010-11-316935

Published: 2011

Journal Articles

The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences?

Curtis A. Hanson, Paul J. Kurtin, Ahmet Dogan

Blood (2009) 113 (25): 6495–6496.

https://doi.org/10.1182/blood-2008-05-158444

Published: 2009

Journal Articles

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

Wee J. Chng, Ellen D. Remstein, Rafael Fonseca, P. Leif Bergsagel, Julie A. Vrana, Paul J. Kurtin, Ahmet Dogan

Blood (2009) 113 (3): 635–645.

https://doi.org/10.1182/blood-2008-02-140996

Published: 2009

Includes: Supplemental data

Journal Articles

Gene Expression Profiling of Post-Follicular B-Cell Lymphoma

Wee-Joo Chng, Gaofeng Huang, Paul J. Kurtin, Ahmet Dogan, M.D., Ph.D., Ellen Remstein

Blood (2008) 112 (11): 617.

https://doi.org/10.1182/blood.V112.11.617.617

Published: 2008

Journal Articles

Diagnosis and Classification of Amyloidosis in Abdominal Subcutaneous Fat Aspiration Specimens Using Mass Spectrometry Based Proteomics

Julie A. Vrana, Ph.D., Steven R. Zeldenrust, M.D., Ph.D., Jason D. Theis, Jeffrey D. Gamez, Paul J. Kurtin, M.D., Ahmet Dogan, M.D., Ph.D.

Blood (2008) 112 (11): 2710.

https://doi.org/10.1182/blood.V112.11.2710.2710

Published: 2008

Journal Articles

Del(6)(q22) and BCL6 Rearrangements in Primary Central Nervous System Lymphoma (PCNSL) Are Indicators of an Aggressive Clinical Course.

Francois M. Cady, MD, Mark E. Law, MS, Caterina Giannini, MD, Alyx B. Porter, MD, Brian P. O’Neill, MD, Paul A. Decker, MD, Paul J. Kurtin, MD, Ellen D. Remstein, MD, Ahmet Dogan, MD

Blood (2007) 110 (11): 1557.

https://doi.org/10.1182/blood.V110.11.1557.1557

Published: 2007

NARROW

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Immunoglobulin Variable Region Family Usage and Outcomes of Patients with Systemic Light Chain Amyloidosis

Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Mass Spectrometry-Based Proteomics Reveals Distinct Immunoglobulin Light Chain Variable Region Usage In Systemic Versus Localized AL Amyloidosis

Proteome Of Amyloidosis: Mayo Clinic Experience In 4139 Cases

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients

The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences?

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

Gene Expression Profiling of Post-Follicular B-Cell Lymphoma

Diagnosis and Classification of Amyloidosis in Abdominal Subcutaneous Fat Aspiration Specimens Using Mass Spectrometry Based Proteomics

Del(6)(q22) and BCL6 Rearrangements in Primary Central Nervous System Lymphoma (PCNSL) Are Indicators of an Aggressive Clinical Course.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only